AbbVie Inc.

AbbVie Inc. is a leading global biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of innovative pharmaceuticals. Established as a spin-off from Abbott Laboratories in 2013, AbbVie focuses primarily on advanced therapies in immunology, oncology, neuroscience, and virology. Its product portfolio includes notable drugs such as Humira for autoimmune diseases, Skyrizi and Rinvoq for psoriasis and arthritis, as well as oncology treatments like Imbruvica and Venclexta. The company has expanded its pipeline and therapeutic reach through strategic acquisitions, including Allergan, which added aesthetic products like Botox, and more recent acquisitions in neuroscience and oncology. AbbVie plays a significant role in the healthcare sector by providing treatments addressing complex and chronic conditions, with a strong emphasis on innovation and broad market impact.